In the D-Gal + FOXO4-DRI group, mice also received D-galactose injections and, after 4 weeks, were given intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days for 4 weeks, followed by tissue collection
By contrast, overexpression of G6PD in NIH 3T3 cells leads to anchorage-independent growth (11)
What are the differences between semaglutide vs retatrutide
The FDA agreed in September 2025 to accept lean mass and fat mass as co-primary endpoints, which could set a regulatory precedent for the entire category
They do not require the same frequent blood testing
Jump to: Side effects by dose | Stomach and gut side effects | Heart rate and irregular heartbeats | Dysesthesia: skin sensation changes | Muscle loss during rapid weight loss | Mental health and mood | Drug interactions and contraception | Other side effects | How retatrutide compares to Mounjaro and Wegovy | Discontinuation and weight regain | What we dont yet know | When to speak to a healthcare professional | FAQ | Take home message | Second Natures Mounjaro programme | References Retatrutides side effects fall into three main groups: stomach and gut symptoms during dose increases, a heart-rate increase larger than other GLP-1 medications, and a skin sensation called dysesthesia that emerged at higher doses in Phase 3 trials